The impressively low cost and improved quality of genome sequencing provides to researchers of genetic diseases, such as cancer, a powerful tool to better understand the underlying genetic mechanisms of those diseases and treat them with effective targeted therapies. Thus, a number of projects today sequence the DNA of large patient populations each of which produces at least hundreds of terra-bytes of data. Now the challenge is to provide the produced data on demand to interested parties.